Stay updated on EMPIRE CF: CTX-4430 Clinical Trial
Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe changes appear to be minor UI/layout updates to the Study Details page with no impact on core trial information such as eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference3%

- Check45 days agoChange DetectedUpdate to v3.1.0 with removal of several named drug-safety topics from the page, indicating a scope shift and version upgrade.SummaryDifference0.4%

- Check59 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, replacing the older tag. The 'Back to Top' link was removed, indicating a minor UI cleanup.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check73 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific locations related to drug safety and cystic fibrosis, while also removing previous location terms and some medical terminology.SummaryDifference2%

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.